bunrab: (Default)
[personal profile] bunrab
From Health Day:
Multaq Sanctioned for Heart Rhythm Disorders
Atrial fibrillation or atrial flutter

THURSDAY, July 2 (HealthDay News) -- Multaq (dronedarone) tablets have been approved by the U.S. Food and Drug Administration to promote a normal heart rhythm in people with atrial fibrillation or atrial flutter. These conditions cause the heart to beat too quickly and can prevent it from pumping blood correctly.

The drug's label, however, will contain a "black box" warning that the medication could cause deadly reactions in people with recent severe heart failure, the agency said Thursday in a news release.

In clinical testing involving more than 4,000 people, Multaq lowered the rates of cardiac hospitalization or death from any cause by 24 percent, compared to an inactive placebo, the FDA said. The most common side effects were diarrhea, nausea, vomiting, fatigue and weakness.

Multaq is produced by French drug maker Sanofi-Aventis.

More information

The FDA has more about this approval.

Encouraged

Date: 2009-07-30 02:33 am (UTC)
From: [identity profile] heartsmending.blogspot.com (from livejournal.com)
Reading your blog has encouraged me!

Re: Encouraged

Date: 2009-08-01 12:23 am (UTC)
From: [identity profile] bunrab.livejournal.com
I'm glad to help! Thank you!

Profile

bunrab: (Default)
bunrab

February 2017

S M T W T F S
   1234
567891011
121314151617 18
19202122232425
262728    

Most Popular Tags

Style Credit

Expand Cut Tags

No cut tags
Page generated Feb. 27th, 2017 11:10 am
Powered by Dreamwidth Studios